News | April 10, 2024
Lupin launches first generic version of Oracea in US
Doxycycline Capsules, 40 mg is indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients
Doxycycline Capsules, 40 mg is indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) Prozac Tablets of Eli Lilly
Abecma tripled progression-free survival compared to standard regimens in the Phase 3 KarMMa-3 trial
TriClip offers a remarkably safe, minimally invasive treatment option for patients in need of tricuspid valve repair but who are unable to withstand surgery
New leadership team announced at NATHEALTH Annual General Meeting 2024
The facility will manufacture tablets, capsules, and injections for the oncology segment
This partnership combines Tata Elxsi's design and technology expertise along with Dräger's expertise in medical and safety technology
First and only long-acting C5 complement inhibitor offers patients with AQP4 Ab+
More than 10,000 scientific publications containing EUDRAGIT
CRESEMBA receives seven years and six months of US market exclusivity for these pediatric indications
Subscribe To Our Newsletter & Stay Updated
